TABLE 2.
Recency Duration (MDRI) and FRR
| MDRI (Days) | FRR (%) | ||||||
|---|---|---|---|---|---|---|---|
| Country | Method | Reduction | Context-specific (se) | Ref. | Reduction | Residual (se) | Ref. |
| Cameroon | External | −14 | 115.6 (0) | 134.20 | −59 | 0.23 (0.012) | 0.55 |
| Negative | −12 | 118.5 (0.4) | 134.20 | −61 | 0.22 (0.013) | 0.55 | |
| Undiagnosed | −15 | 114.1 (2.3) | 134.20 | −60 | 0.22 (0.012) | 0.55 | |
| Cote d’Ivoire |
External | −7 | 125.3 (0) | 134.20 | −52 | 0.27 (0.02) | 0.55 |
| Negative | −5 | 127.2 (0.3) | 134.20 | −52 | 0.26 (0.02) | 0.55 | |
| Undiagnosed | −7 | 124.3 (1.7) | 134.20 | −52 | 0.27 (0.02) | 0.55 | |
| Eswatini | External | −30 | 94.1 (0) | 134.20 | −89 | 0.06 (0.004) | 0.55 |
| Negative | −29 | 95.7 (0.6) | 134.20 | −90 | 0.05 (0.005) | 0.55 | |
| Undiagnosed | −29 | 94.8 (7.2) | 134.20 | −90 | 0.06 (0.004) | 0.55 | |
| Ethiopia | External | −8 | 123.2 (0) | 134.20 | −81 | 0.1 (0.013) | 0.55 |
| Negative | −9 | 122 (0.3) | 134.20 | −81 | 0.1 (0.013) | 0.55 | |
| Undiagnosed | −9 | 121.7 (7.2) | 134.20 | −81 | 0.1 (0.013) | 0.55 | |
| Lesotho | External | −27 | 97.5 (0) | 134.20 | −83 | 0.09 (0.004) | 0.55 |
| Negative | −30 | 94.6 (0.6) | 134.20 | −84 | 0.09 (0.005) | 0.55 | |
| Undiagnosed | −34 | 88.4 (0.3) | 134.20 | −83 | 0.09 (0.004) | 0.55 | |
| Malawi | External | −11 | 119.6 (0) | 134.20 | −83 | 0.1 (0.007) | 0.55 |
| Negative | −17 | 112.1 (0.5) | 134.20 | −82 | 0.1 (0.007) | 0.55 | |
| Undiagnosed | −20 | 107.9 (0.9) | 134.20 | −82 | 0.1 (0.006) | 0.55 | |
| Namibia | External | −15 | 113.5 (0) | 134.20 | −88 | 0.07 (0.008) | 0.55 |
| Negative | −16 | 113.2 (0.4) | 134.20 | −88 | 0.06 (0.008) | 0.55 | |
| Undiagnosed | −21 | 106 (8.4) | 134.20 | −88 | 0.07 (0.008) | 0.55 | |
| Rwanda | External | −17 | 111.3 (0) | 134.20 | −87 | 0.07 (0.009) | 0.55 |
| Negative | −10 | 120.9 (0.3) | 134.20 | −88 | 0.06 (0.009) | 0.55 | |
| Undiagnosed | −13 | 116.9 (2.1) | 134.20 | −88 | 0.07 (0.009) | 0.55 | |
| Tanzania | External | −12 | 118.1 (0) | 134.20 | −67 | 0.18 (0.01) | 0.55 |
| Negative | −12 | 118.1 (0.3) | 134.20 | −67 | 0.18 (0.011) | 0.55 | |
| Undiagnosed | −15 | 113.7 (1.3) | 134.20 | −67 | 0.18 (0.01) | 0.55 | |
| Uganda | External | −20 | 107.7 (0) | 134.20 | −79 | 0.11 (0.008) | 0.55 |
| Negative | −17 | 111.7 (0.4) | 134.20 | −81 | 0.11 (0.009) | 0.55 | |
| Undiagnosed | −22 | 104.7 (0.4) | 134.20 | −80 | 0.11 (0.009) | 0.55 | |
| Zambia | External | −12 | 118.1 (0) | 134.20 | −77 | 0.13 (0.008) | 0.55 |
| Negative | −17 | 111.2 (0.4) | 134.20 | −77 | 0.13 (0.008) | 0.55 | |
| Undiagnosed | −25 | 100.8 (4.5) | 134.20 | −76 | 0.13 (0.008) | 0.55 | |
| Zimbabwe | External | −12 | 117.6 (0) | 134.20 | −79 | 0.12 (0.006) | 0.55 |
| Negative | −16 | 112.7 (0.4) | 134.20 | −79 | 0.12 (0.006) | 0.55 | |
| Undiagnosed | −20 | 107.3 (2.8) | 134.20 | −78 | 0.12 (0.006) | 0.55 | |
Reference (Ref.) value MDRI () and FRR () values are calculated from reference studies in untreated populations. Context-specific MDRI () and FRR () values are estimated for the study population after the application of RITA3 screening. Time to diagnosis estimation is estimated using either the testing history of the undiagnosed HIV-positive population, the testing history of the HIV-negative population, or from an external study. Reduction is the percent reduction of the context-specific (or residual) value compared to the reference value. (se) indicates jackknife standard error.